Skip to main content
Erschienen in: Clinical and Experimental Nephrology 4/2009

01.08.2009 | Original Article

Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults

verfasst von: Kei Matsushita, Gen Yasuda, Masataka Shouda, Satoshi Umemura

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Although obesity is recognized to be a risk factor for chronic kidney disease (CKD), few studies have reported the association between obesity and CKD in the young population. We investigated the relationship between obesity and renal function including proteinuria in young Japanese.

Methods

This cross-sectional study consisted of 16,031 men and 5,746 women aged from 20 to 39 years who received health examinations. The subjects were stratified into four age groups (20–24, 25–29, 30–34, and 35–39 years) or into four groups based on the number of risk factors (hypertension, hyperglycemia, dyslipidemia, and hyperuricemia). The relationship between obesity and risk factors and the relationship between obesity and estimated glomerular filtration rate (eGFR) were analyzed.

Results

There were no significant differences in eGFR between obese and nonobese groups, except in the male 35–39 years age group. Body mass index (BMI) in both men and women increased with increase in number of risk factors (P < 0.001). Multivariate analysis revealed that hypertension, hyperglycemia, dyslipidemia, and hyperuricemia were independently associated with obesity. Obesity and the risk factors were independently associated with proteinuria.

Conclusion

The present study indicated that obesity was an independent risk factor for proteinuria in healthy subjects younger than 40 years of age. The other risk factors were independently associated with obesity. These findings suggest that obesity causes proteinuria concomitantly with other risk factors such as hypertension, diabetes, and dyslipidemia in young adults.
Literatur
1.
Zurück zum Zitat National Health and Nutrition Survey: the Ministry of Health, Labor and Welfare of Japan, 2005. National Health and Nutrition Survey: the Ministry of Health, Labor and Welfare of Japan, 2005.
2.
Zurück zum Zitat Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.CrossRefPubMed Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–69.CrossRefPubMed
3.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.CrossRefPubMed
4.
Zurück zum Zitat Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167–74.CrossRefPubMed
5.
Zurück zum Zitat Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16:2134–40.CrossRefPubMed
6.
Zurück zum Zitat Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int. 2006;69:369–74.CrossRefPubMed
7.
Zurück zum Zitat Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383–91.CrossRefPubMed Ninomiya T, Kiyohara Y, Kubo M, Yonemoto K, Tanizaki Y, Doi Y. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis. 2006;48:383–91.CrossRefPubMed
8.
Zurück zum Zitat Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients. Int Heart J. 2006;47:343–50.CrossRefPubMed Azegami M, Hongo M, Yanagisawa S, Yamazaki A, Sakaguchi K, Yazaki Y, et al. Characteristics of metabolic and lifestyle risk factors in young Japanese patients with coronary heart disease: a comparison with older patients. Int Heart J. 2006;47:343–50.CrossRefPubMed
9.
Zurück zum Zitat Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young Japanese patients: a comparison with older patients. Circ J. 2005;69:1176–9.CrossRefPubMed Azegami M, Hongo M, Yazaki Y, Yanagisawa S, Yamazaki A, Imamura H. Seasonal difference in onset of coronary heart disease in young Japanese patients: a comparison with older patients. Circ J. 2005;69:1176–9.CrossRefPubMed
10.
Zurück zum Zitat Horio M, Imai E, Yasuda N, Hishida A, Matsuo S. Estimation of glomerular filtration rate for Japanese. J Jpn Soc Nephrol. 2008;50:221. (in Japanese abstract). Horio M, Imai E, Yasuda N, Hishida A, Matsuo S. Estimation of glomerular filtration rate for Japanese. J Jpn Soc Nephrol. 2008;50:221. (in Japanese abstract).
11.
Zurück zum Zitat Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794–809. (in Japanese with English abstract).CrossRef Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Intern Med. 2005;94:794–809. (in Japanese with English abstract).CrossRef
12.
Zurück zum Zitat Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality. J Rheumatol. 2005;32:906–12.PubMed Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, et al. Serum uric acid concentration as a risk factor for cardiovascular mortality. J Rheumatol. 2005;32:906–12.PubMed
13.
Zurück zum Zitat Examination committee of criteria for ‘obesity disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRef Examination committee of criteria for ‘obesity disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRef
15.
Zurück zum Zitat Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029–33.CrossRefPubMedPubMedCentral Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029–33.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92–6.PubMed Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92–6.PubMed
17.
Zurück zum Zitat Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.CrossRefPubMed Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, et al. Obesity-related glomerulopathy: insight from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology. 2006;147:44–50.CrossRefPubMed
18.
Zurück zum Zitat Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59:1498–509.CrossRefPubMed
19.
Zurück zum Zitat Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008;52:58–65.CrossRefPubMed Chen HM, Li SJ, Chen HP, Wang QW, Li LS, Liu ZH. Obesity-related glomerulopathy in China: a case series of 90 patients. Am J Kidney Dis. 2008;52:58–65.CrossRefPubMed
20.
Zurück zum Zitat Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–22.CrossRefPubMed Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817–22.CrossRefPubMed
21.
Zurück zum Zitat Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831–43.CrossRefPubMed Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens. 2008;26:831–43.CrossRefPubMed
22.
Zurück zum Zitat Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48.CrossRefPubMedPubMedCentral Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis. 2008;52(1):39–48.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.CrossRefPubMed Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.CrossRefPubMed
24.
Zurück zum Zitat Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight changes on albuminuria in the general population. Nephrol Dial Tranplant. 2007;20:1619–27.CrossRef Bello AK, de Zeeuw D, El Nahas M, Brantsma AH, Bakker SJ, de Jong PE, et al. Impact of weight changes on albuminuria in the general population. Nephrol Dial Tranplant. 2007;20:1619–27.CrossRef
25.
Zurück zum Zitat Watanabe N, Hashimoto Y, Futamura A, Mashige F, Nakarai H, Nakahara K. Relationship between the prevalence of proteinuria and obesity in Japanese men. Rinsho Byori. 1999;47:271–4.PubMed Watanabe N, Hashimoto Y, Futamura A, Mashige F, Nakarai H, Nakahara K. Relationship between the prevalence of proteinuria and obesity in Japanese men. Rinsho Byori. 1999;47:271–4.PubMed
26.
Zurück zum Zitat Tozawa M, Iseki K, Iseki C, Oshiro S, Ikeyama Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed Tozawa M, Iseki K, Iseki C, Oshiro S, Ikeyama Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int. 2002;62:956–62.CrossRefPubMed
27.
Zurück zum Zitat Remuzzi G, Weening JJ. Albuminuria as early test for vascular disease. Lancet. 2005;365:556–7.CrossRefPubMed Remuzzi G, Weening JJ. Albuminuria as early test for vascular disease. Lancet. 2005;365:556–7.CrossRefPubMed
28.
Zurück zum Zitat de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;66:2109–18.CrossRefPubMed de Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;66:2109–18.CrossRefPubMed
Metadaten
Titel
Evaluation of renal function and proteinuria based on mass health examinations in young Japanese obese adults
verfasst von
Kei Matsushita
Gen Yasuda
Masataka Shouda
Satoshi Umemura
Publikationsdatum
01.08.2009
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 4/2009
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0164-8

Weitere Artikel der Ausgabe 4/2009

Clinical and Experimental Nephrology 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.